Gi Archives - Infectious Disease Advisor

Researchers evaluated the association between diarrheagenic E coli and development of reactive arthritis and musculoskeletal symptoms among international travelers.

GI Illness

Pharmacokinetic Analysis of an Extended-Pulsed Fidaxomicin Regimen

By

Bradley van Paridon

April 23, 2020

Extended-pulsed fidaxomicin regimen for treatment of C difficile infection maintained fidaxomicin stool concentrations above the minimum inhibitory concentration required to inhibit the growth of 90% of organisms for 26 days.

COVID19

Low-Severity COVID-19 May Be Associated With Gastrointestinal Symptoms

By

Infectious Disease Advisor Contributing Writer

April 15, 2020

A subset of patients with coronavirus disease 2019 (COVID-19) may present with low disease severity marked only by digestive symptoms.

Prevention

Prophylaxis for Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis

By

Bradley van Paridon

April 10, 2020

There remains considerable uncertainty on whether antibiotic prophylaxis for spontaneous bacterial peritonitis is beneficial in people with liver cirrhosis.

Clostridioides Difficile

Burden of Clostridioides difficile Infection Down in the U.S.

April 7, 2020

From 2011 to 2017, there was a decrease in the estimated national burden of Clostridium difficile infection.

E. coli

Case Highlights Need for Adequate Neutrophil Count and Function in the Clearance of E coli Bacteremia

By

Sweta Gupta

March 6, 2020

Study shows ST-167, ST-940, and the isolate with an unidentifiable sequence type were cultured from blood and carried the blaNDM-5 gene, conferring phenotypic carbapenem resistance.

GI Illness

Multiple Sclerosis Susceptibility Associated With Certain Gut Bacteria

By

Infectious Disease Advisor Contributing Writer

March 4, 2020

A network of gut bacteria species may be associated with host genetic factors that increase susceptibility to multiple sclerosis.

Clostridioides Difficile

Changes in Microbiota Predictive of Recurrent C Difficile Infection Risk

By

Infectious Disease Advisor Contributing Writer

March 2, 2020

Features of fecal microbiota at baseline and after antibiotic therapy may be predictive of recurrent Clostridiodes difficile infection in patients with and without ulcerative colitis.